High rates of quinolone resistance among urinary tract infections in the ED

American Journal of Emergency Medicine

Volumn 30, Issue 1, 2012, Pages 68-74

  Khawcharoenporn, Thana ^a   Vasoo, Shawn ^b   Ward, Edward ^b   Singh, Kamaljit ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN; PENICILLIN G; QUINOLONE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER; EMERGENCY WARD; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROCYSTIS AERUGINOSA; NONHUMAN; PRIORITY JOURNAL; PROTEUS; RETROSPECTIVE STUDY; RISK FACTOR; SERRATIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SAPROPHYTICUS; TREATMENT DURATION; URINARY CATHETER; URINARY TRACT INFECTION; UROLOGY;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN; QUINOLONES; RETROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 81755171889     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2010.09.030     Document Type: Article

References (22)

1. Abrahamian F.M., Moran G.J., and Talan D.A. Urinary tract infections in the emergency department Infect Dis Clin North Am 22 2008 73 87
2. Talan D.A., Krishnadasan A., and Abrahamian F.M. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis Clin Infect Dis 47 2008 1150 1158
3. Zhanel G.G., Hisanaga T.L., and Laing N.M. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) Int J Antimicrob Agents 26 2005 380 388
4. Johnson L., Sabel A., and Burman W.J. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates Am J Med 121 2008 876 884
5. Colodner R., Kometiani I., and Chazan B. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli Infection 36 2008 41 45
6. Karlowsky J.A., Hoban D.J., and Decorby M.R. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study Antimicrob Agents Chemother 50 2006 2251 2254
7. Olson R.P., Harrell L.J., and Kaye K.S. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections Antimicrob Agents Chemother 53 2009 1285 1286
8. Warren J.W., Abrutyn E., and Hebel J.R. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 29 1999 745 758
9. Rubin R.H., Beam T.R. Jr, and Stamm W.E. An approach to evaluating antibacterial agents in the treatment of urinary tract infection Clin Infect Dis 14 1992 S246 251
10. Horan T.C., Andrus M., and Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
11. American Thoracic Society and Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
12. Clinical Laboratory Standards Institue Performance standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100-S17 2007 Clinical and Laboratory Standards Institute Wayne, PA
13. Raz R., Chazan B., and Kennes Y. Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens Clin Infect Dis 34 2002 1165 1169
14. Talan D.A., Stamm W.E., and Hooton T.M. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial JAMA 283 2000 1583 1590
15. Kahlmeter G. ECO.SENS: a n international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project J Antimicrob Chemother 51 2003 69 76
16. Colgan R., Johnson J.R., and Kuskowski M. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis Antimicrob Agents Chemother 52 2008 846 851
17. Smith S.P., Manges A.R., and Riley L.W. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition Clin Infect Dis 46 2008 689 695
18. Arslan H., Azap O.K., and Ergönül O. Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J Antimicrob Chemother 56 2005 914 918
19. Killgore K.M., March K.L., and Guglielmo B.J. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection Ann Pharmacother 38 2004 1148 1152
20. Cagnacci S., Gualco L., and Debbia E. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis J Clin Microbiol 46 2008 2605 2612
21. Hoban D.J., Bouchillon S.K., and Hawser S.P. Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) Antimicrob Agents Chemother 54 2010 3031 3034
22. Solomkin J.S., Mazuski J.E., and Bradley J.S. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clin Infect Dis 50 2010 133 164